Less axillary node dissection necessary owing to sentinel node biopsy in breast cancer patients;Minder okselklierdissectie nodig door schildwachtklierbiopsie bij patienten met mammacarcinoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 45, 1996, Pages 2239-2243

  Meijer, S ^a   Collet, G J ^a   Pijpers, H J ^a   Van Hattum, L ^a   Hoekstra, O S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; SCINTIGRAPHY;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0029805611     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands. Third report of the Netherlands cancer registry. Utrecht Vereniging van Integrale Kankercentra, 1991:26-31.
2. Fisher B, Slack N, Katrych D, Wolmark N. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy Surg Gynecol Obstet 1975;140:528-34.
3. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 1978;41:1170-8.
4. Schottenfeld D, Nash AG, Robbins GF, Beattie jr EJ. Ten-year results of the treatment of primary operable breast carcinoma: a summary of 304 patients evaluated by the TNM system Cancer 1976, 38:1001-7.
5. De Vita jr VT. Breast cancer therapy: exercising all our options. N Engl J Med 1989;320:527-9.
6. McGuire WL. Adjuvant therapy of node-negative breast cancer. N Engl J Med 1989;320:525-7.
7. McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM. How to use prognostic factors in axillary node-negative breast cancer patients J Natl Cancer Inst 1990;82:1006-15.
8. National Institute for Health consensus conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5
9. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
10. Assa J. The intercostobrachial nerve in radical mastectomy. J Surg Oncol 1974;6:123-6.
11. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575-82.
12. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993; 36:315-20.
13. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for Tia breast carcinoma. Cancer 1994;73:664-7.
14. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
15. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
16. Veen H van der, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81.1769-70.
17. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-60.
18. Meijer S, Pijpers HJ, Veen H van der, Paul MA, Hattum AH van, Hoekstra OS. Schildwachtklieronderzoek om melanoompatiënten te selecteren voor regionale lymfklierdissectie. Ned Tijdschr Geneeskd 1994;138:2491-5.
19. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
20. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
21. Makkink-Nombrado SV, Baak JPA, Diest PJ van, Broeckaert M, Schuurmans L, Brugghe J, et al. Comparison of classic prognostic factors with quantitative pathologic, cell- and molecular biologic features in premenopausal breast cancer [proefschrift]. Amsterdam: Vrije Universiteit, 1995.
22. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
23. Nichols PH, Ibrahim NBN, Padfield CJH, Cawthorn SJ. Correlation of pS2 expression of involved lymph nodes in relation to primary breast carcinoma. Eur J Surg Oncol 1995;21:151-4.
24. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-80.
25. Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995,22:1238-41.